Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Cytomegaloviruses Exploit Recycling Rab Proteins in the Sequential Establishment of the Assembly Compartment.

Lučin P, Kareluša L, Blagojević Zagorac G, Mahmutefendić Lučin H, Pavišić V, Jug Vučko N, Lukanović Jurić S, Marcelić M, Lisnić B, Jonjić S.

Front Cell Dev Biol. 2018 Dec 4;6:165. doi: 10.3389/fcell.2018.00165. eCollection 2018. Review.

2.

Severe Traumatic Brain Injury Induces Early Changes in the Physical Properties and Protein Composition of Intracranial Extracellular Vesicles.

Kuharić J, Grabušić K, Tokmadžić VS, Štifter S, Tulić K, Shevchuk O, Lučin P, Šustić A.

J Neurotrauma. 2019 Jan 15;36(2):190-200. doi: 10.1089/neu.2017.5515. Epub 2018 Aug 10.

PMID:
29690821
3.

Landmarks of endosomal remodeling in the early phase of cytomegalovirus infection.

Karleuša L, Mahmutefendić H, Tomaš MI, Zagorac GB, Lučin P.

Virology. 2018 Feb;515:108-122. doi: 10.1016/j.virol.2017.12.001. Epub 2017 Dec 22.

4.

Quantitative Analysis of Endocytic Recycling of Membrane Proteins by Monoclonal Antibody-Based Recycling Assays.

Blagojević Zagorac G, Mahmutefendić H, Maćešić S, Karleuša L, Lučin P.

J Cell Physiol. 2017 Mar;232(3):463-476. doi: 10.1002/jcp.25503. Epub 2016 Aug 22.

PMID:
27458974
5.

Late Endosomal Recycling of Open MHC-I Conformers.

Mahmutefendić H, Blagojević Zagorac G, Grabušić K, Karleuša L, Maćešić S, Momburg F, Lučin P.

J Cell Physiol. 2017 Apr;232(4):872-887. doi: 10.1002/jcp.25495. Epub 2016 Jul 27.

PMID:
27438986
6.

Cytomegalovirus immune evasion by perturbation of endosomal trafficking.

Lučin P, Mahmutefendić H, Blagojević Zagorac G, Ilić Tomaš M.

Cell Mol Immunol. 2015 Mar;12(2):154-69. doi: 10.1038/cmi.2014.85. Epub 2014 Sep 29. Review.

7.

Endosomal trafficking of open Major Histocompatibility Class I conformers--implications for presentation of endocytosed antigens.

Mahmutefendić H, Zagorac GB, Tomaš MI, Groettrup M, Momburg F, Lučin P.

Mol Immunol. 2013 Sep;55(2):149-52. doi: 10.1016/j.molimm.2012.10.008. Epub 2012 Nov 27. Review.

PMID:
23200229
8.

Early endosomal rerouting of major histocompatibility class I conformers.

Zagorac GB, Mahmutefendić H, Tomaš MI, Kučić N, Le Bouteiller P, Lučin P.

J Cell Physiol. 2012 Jul;227(7):2953-64. doi: 10.1002/jcp.23042.

PMID:
21959869
9.

A new N-methyl thymine derivative comprising a dihydroxyisobutenyl unit as ligand for thymidine kinase of herpes simplex virus type 1 (HSV-1 TK).

Krištafor S, Novaković I, Gazivoda Kraljević T, Kraljević Pavelić S, Lučin P, Westermaier Y, Pernot L, Scapozza L, Ametamey SM, Raić-Malić S.

Bioorg Med Chem Lett. 2011 Oct 15;21(20):6161-5. doi: 10.1016/j.bmcl.2011.07.115. Epub 2011 Aug 6.

PMID:
21911293
10.

Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.

Hranjec M, Starčević K, Pavelić SK, Lučin P, Pavelić K, Karminski Zamola G.

Eur J Med Chem. 2011 Jun;46(6):2274-9. doi: 10.1016/j.ejmech.2011.03.008. Epub 2011 Mar 10.

PMID:
21439689
11.

Segregation of open Major Histocompatibility Class I conformers at the plasma membrane and during endosomal trafficking reveals conformation-based sorting in the endosomal system.

Mahmutefendić H, Blagojević G, Tomaš MI, Kučić N, Lučin P.

Int J Biochem Cell Biol. 2011 Apr;43(4):504-15. doi: 10.1016/j.biocel.2010.12.002. Epub 2010 Dec 21.

PMID:
21176792
12.

Murine cytomegalovirus perturbs endosomal trafficking of major histocompatibility complex class I molecules in the early phase of infection.

Tomas MI, Kucić N, Mahmutefendić H, Blagojević G, Lucin P.

J Virol. 2010 Nov;84(21):11101-12. doi: 10.1128/JVI.00988-10. Epub 2010 Aug 18.

13.

Early changes in frequency of peripheral blood lymphocyte subpopulations in severe traumatic brain-injured patients.

Mrakovcic-Sutic I, Tokmadzic VS, Laskarin G, Mahmutefendic H, Lucin P, Zupan Z, Sustic A.

Scand J Immunol. 2010 Jul;72(1):57-65. doi: 10.1111/j.1365-3083.2010.02407.x.

14.

Expression of cytolytic protein-perforin in peripheral blood lymphocytes in severe traumatic brain injured patients.

Sotosek Tokmadzic V, Laskarin G, Mahmutefendic H, Lucin P, Mrakovcic-Sutic I, Zupan Z, Sustic A.

Injury. 2012 May;43(5):624-31. doi: 10.1016/j.injury.2010.05.009. Epub 2010 May 26.

PMID:
20537642
15.

Constitutive internalization of murine MHC class I molecules.

Mahmutefendić H, Blagojević G, Kucić N, Lucin P.

J Cell Physiol. 2007 Feb;210(2):445-55.

PMID:
17044074
16.

Inhibition of protein kinases C prevents murine cytomegalovirus replication.

Kucić N, Mahmutefendić H, Lucin P.

J Gen Virol. 2005 Aug;86(Pt 8):2153-61.

PMID:
16033962
17.

Pathogenesis of murine cytomegalovirus infection.

Krmpotic A, Bubic I, Polic B, Lucin P, Jonjic S.

Microbes Infect. 2003 Nov;5(13):1263-77. Review.

PMID:
14623023
18.

Distinct pathways for constitutive endocytosis of fully conformed and non-conformed L(d) molecules.

Mahmutefendić H, Kucić N, Lucin P.

Am J Reprod Immunol. 2002 Aug;48(2):87-95.

PMID:
12389597
19.

Cytomegaloviral control of MHC class I function in the mouse.

Hengel H, Reusch U, Gutermann A, Ziegler H, Jonjic S, Lucin P, Koszinowski UH.

Immunol Rev. 1999 Apr;168:167-76. Review.

PMID:
10399073
20.

A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation.

Reusch U, Muranyi W, Lucin P, Burgert HG, Hengel H, Koszinowski UH.

EMBO J. 1999 Feb 15;18(4):1081-91.

21.

Protective effect of antilipopolysaccharide monoclonal antibody in experimental Klebsiella infection.

Rukavina T, Tícac B, Susa M, Jendrike N, Jonjíc S, Lucin P, Marre R, Doríc M, Trautmann M.

Infect Immun. 1997 May;65(5):1754-60.

22.

A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface.

Kleijnen MF, Huppa JB, Lucin P, Mukherjee S, Farrell H, Campbell AE, Koszinowski UH, Hill AB, Ploegh HL.

EMBO J. 1997 Feb 17;16(4):685-94.

23.

A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments.

Ziegler H, Thale R, Lucin P, Muranyi W, Flohr T, Hengel H, Farrell H, Rawlinson W, Koszinowski UH.

Immunity. 1997 Jan;6(1):57-66.

24.

Lack of MHC class I complex expression has no effect on spread and control of cytomegalovirus infection in vivo.

Polić B, Jonjić S, Pavić I, Crnković I, Zorica I, Hengel H, Lucin P, Koszinowski UH.

J Gen Virol. 1996 Feb;77 ( Pt 2 ):217-25.

PMID:
8627225
25.

Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport.

Thäle R, Szepan U, Hengel H, Geginat G, Lucin P, Koszinowski UH.

J Virol. 1995 Oct;69(10):6098-105.

26.

Immunosuppressive and antiproliferative effects of somatostatin analog SMS 201-995.

Radosević-Stasić B, Trobonjaca Z, Lucin P, Cuk M, Polić B, Rukavina D.

Int J Neurosci. 1995 Apr;81(3-4):283-97.

PMID:
7628916
27.

Characterization of a conserved gene block in the murine cytomegalovirus genome.

Messerle M, Rapp M, Lucin P, Koszinowski UH.

Virus Genes. 1995;10(1):73-80.

PMID:
7483291
28.

Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor.

Thäle R, Lucin P, Schneider K, Eggers M, Koszinowski UH.

J Virol. 1994 Dec;68(12):7757-65.

29.

The establishment of cytomegalovirus latency in organs is not linked to local virus production during primary infection.

Balthesen M, Dreher L, Lucin P, Reddehase MJ.

J Gen Virol. 1994 Sep;75 ( Pt 9):2329-36.

PMID:
8077931
30.

Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus.

Jonjić S, Pavić I, Polić B, Crnković I, Lucin P, Koszinowski UH.

J Exp Med. 1994 May 1;179(5):1713-7.

31.

Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape.

Hengel H, Lucin P, Jonjić S, Ruppert T, Koszinowski UH.

J Virol. 1994 Jan;68(1):289-97.

32.

Expression of the murine cytomegalovirus glycoprotein H by recombinant vaccinia virus.

Rapp M, Lucin P, Messerle M, Loh LC, Koszinowski UH.

J Gen Virol. 1994 Jan;75 ( Pt 1):183-8.

PMID:
8113726
33.

Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor.

Lucin P, Jonjić S, Messerle M, Polić B, Hengel H, Koszinowski UH.

J Gen Virol. 1994 Jan;75 ( Pt 1):101-10.

PMID:
8113718
34.

Participation of endogenous tumour necrosis factor alpha in host resistance to cytomegalovirus infection.

Pavić I, Polić B, Crnković I, Lucin P, Jonjić S, Koszinowski UH.

J Gen Virol. 1993 Oct;74 ( Pt 10):2215-23.

PMID:
8105025
35.
36.

Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands.

Lucin P, Pavić I, Polić B, Jonjić S, Koszinowski UH.

J Virol. 1992 Apr;66(4):1977-84.

37.

Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes.

Jonjić S, Pavić I, Lucin P, Rukavina D, Koszinowski UH.

J Virol. 1990 Nov;64(11):5457-64.

38.

Immunosuppressive properties of halothane anesthesia and/or surgical stress in experimental conditions.

Radosević-Stasić B, Cuk M, Mrakovcić-Sutić I, Barac-Latas V, Muhvić D, Lucin P, Petković M, Rukavina D.

Int J Neurosci. 1990 Apr;51(3-4):235-6. No abstract available.

PMID:
2279874

Supplemental Content

Support Center